Amniocentesis Needle Market Developments and Industry Analysis - Forecast 2022
Factors driving the growth of this market include the high
reliability of the amniocentesis technique, rise in the median age of
first-time motherhood, and increasing burden of congenital disorders are
key factors driving the growth of this market.
According to the new research report amniocentesis needles market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=18541768
The
global amniocentesis needles market covers products that are used to
withdraw amniotic fluid into a syringe. These needles are of special
material and have a long tip which is visible under ultrasound. These
needles are primarily used to perform amniocentesis, an invasive
prenatal diagnostic procedure carried out in the second trimester of
pregnancy.
Major industry players acquired companies and business
units from other companies to maintain and improve their position in
the Amniocentesis Needles Market. Medtronic (Ireland), BD (US),
CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US),
Medline (US), and Cook Medical (US) have been identified as the key
players in this market. These companies have a broad product portfolio
with comprehensive features. These leaders have products for all end
users in this market, and have a strong geographical presence.
Major Market Developments
In
2018, Medline Industries, Inc. (US) completed the acquisition of
Centurion Medical Products (US) to provide a complete set of offerings
that complement its minor procedure tray kits and its growing infection
prevention focus
In 2016, CooperSurgical (US) completed the
acquisition of Wallace, the in-vitro fertilization (IVF) segment of
Smiths Medical, a division of Smiths Group plc, to strengthen product
portfolio and takeover premier products for women’s health
In 2017,
Medtronic established an innovation center in Chengdu, China to provide
advanced training to medical workers in Central and Western China
In
2016, Medline shifted its corporate headquarters to a new,
state-of-the-art facility which is more than double the size of its
current space with a view to adapt to the needs of the rapidly changing
healthcare.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18541768
The
amniocentesis needles market is geographically segmented into North
America, Europe, Asia, and the Rest of the World (RoW). North America is
expected to have the highest growth rate due to the growing number of
initiatives to promote prenatal diagnosis, rapid economic development,
and increasing healthcare expenditure.
Comments
Post a Comment